Amgen shares outstanding AMGN
Diluted shares outstanding, averaged over each quarter, from 1995.
- Latest quarter, to Jun 30, 2026
- 544M
- On a year earlier
- +0.6%
- more shares
Amgen had 544M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 0.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 543M | +0% |
| FY2024 | 542M | +0% |
| FY2023 | 540M | +0% |
| FY2022 | 539M | −5% |
| FY2021 | 565M | −3% |
| FY2020 | 584M | −2% |
| FY2019 | 597M | −7% |
| FY2018 | 641M | −12% |
| FY2017 | 725M | −2% |
| FY2016 | 742M | −3% |
| FY2015 | 763M | −1% |
| FY2014 | 773M | +1% |
| FY2013 | 768M | −2% |
| FY2012 | 781M | −9% |
| FY2011 | 859M | −9% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 544M | +1% | |
| Q1 FY26 | 544M | +1% | |
| Q4 FY25 | 543M | +0% | |
| Q3 FY25 | 542M | +0% | |
| Q2 FY25 | 541M | +0% | |
| Q1 FY25 | 541M | +1% | |
| Q4 FY24 | 542M | +0% | |
| Q3 FY24 | 542M | +1% | |
| Q2 FY24 | 541M | +1% | |
| Q1 FY24 | 536M | −0% | |
| Q4 FY23 | 540M | +0% | |
| Q3 FY23 | 538M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Amgen
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.